# Remed Co., Ltd.

- Location (FDA's records): Daejeon, KR
- FDA decisions: 3 (2021–2022): 3 510(k) clearances
- Product codes: OBP (2), IPF (1)
- 510(k) review time since 2016: median 288 days, against 132 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 4 (1 its own); citations of its devices by later devices: 3 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- The Magstim Company, Ltd.: 1 (https://510kreport.com/company/magstim)
- Teleemg, LLC: 1 (https://510kreport.com/company/teleemg)
- BTL Industries, Inc.: 1 (https://510kreport.com/company/btl-industries)

## Firms that cite its devices most
- Enraf-Nonius, B.V.: 1 (https://510kreport.com/company/enraf-nonius)
- Soterix Medical, Inc.: 1 (https://510kreport.com/company/soterix-medical)

## Its most-cited devices
- K202537: ALTMS Magnetic Stimulation Therapy System (2021), cited by 1
- K220625: ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy System (2022), cited by 1
- K202031: Talent-Pro Electromagnetic Stimulator (2021), cited by 1

## Recent decisions
- K220625: ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy System (Apr 6, 2022)
- K202537: ALTMS Magnetic Stimulation Therapy System (Nov 26, 2021)
- K202031: Talent-Pro Electromagnetic Stimulator (May 6, 2021)

Source page: https://510kreport.com/company/remed